Search

everythinglearnresearchcommunity

for

Search:↓

Hirsutism is excessive hair growth in women often caused by polycystic ovarian syndrome, and identifying the cause is important for managing associated health risks.

Acne severity in women may not be linked to increased male hormone indicators like excess body hair, menstrual irregularities, or hair loss.

Colorimetry can accurately measure hair growth rates in mice.

The number of advanced breast cancer cases in women under 40 has increased, but the overall numbers are still low.

Nonobese, normotensive Indian women with PCOS may have a higher risk of heart problems linked to inflammation and insulin resistance.

Men are increasingly seeking quick-result cosmetic treatments for their thicker, oilier skin and hair loss issues.

Men and women experience skin aging differently due to changes in sex hormone levels with age.

TRP channels in the skin are important for sensation and health, and targeting them could help treat skin disorders.

FGF signaling is a promising target for developing treatments for wounds, metabolic diseases, and cancer.

Acne significantly affects mental health and quality of life, with research suggesting hormonal and genetic factors in its development and emphasizing early treatment to prevent scarring.

Inhibitors of 11β-HSD1 show potential for treating type 2 diabetes but require more testing for safety and effectiveness.

Neurosteroids change how GABA_A receptors work in the brain, which could be important for treating temporal lobe epilepsy.

Certain DNA variants can predict straight hair in Europeans but are not highly specific.

Finasteride and dutasteride effectively stop or reverse hair loss in women with androgenetic alopecia, with dutasteride being more effective for women under 50.

New treatments for PCOS focus on insulin resistance and reducing testosterone levels, along with traditional hormone therapies.

Male hormones worsen kidney transplant damage, but blocking them helps.

Androgenic steroids can slow down or stop the growth of certain skin fungi.

Common types of non-scarring hair loss have various causes and treatments, but more effective solutions are needed.

Older adults still engage in sexual activities but face challenges like health issues and lack of professional support, highlighting the need for better healthcare provider education and research on sexual fulfillment in old age.

New hair loss treatments may include topical medications, injections, and improved transplant methods.

Experts say proper treatment and sensitivity are important for women's facial skin issues like acne and unwanted hair.

The document concludes that hair analysis is not good for assessing nutrition but can detect long-term heavy metal exposure.

SHBG may be a useful early indicator and treatment target for PCOS.

Hormonal imbalances, often indicating conditions like PCOS, are common in women with hard-to-treat acne, and a treatment approach addressing these imbalances may be needed.

A new hair loss classification for women improves treatment, but careful patient selection is crucial for successful hair transplantation.

High doses of cyproterone acetate increase the risk of brain tumors in women, but the risk decreases after stopping the medication.

The document concludes that inflammation markers can be used in diabetes, vitamin D3 affects immune pathways, hyperthyroidism changes hormone levels, androgen levels help diagnose Adrenocortical Carcinoma, erectile dysfunction is linked to diabetes, hypogonadism is common in HIV-infected males, and hormones can be biomarkers for various conditions.

The document suggests that clinical trials for PCOS should focus on meaningful primary outcomes like live birth rates, rather than less reliable surrogate markers.

New liposome treatment successfully delivers CRISPR to deactivate a key enzyme in androgen-related disorders.

Androgens are important for female fertility and could help in IVF treatment, but also play a role in causing PCOS.